In 2019, David P. King earned $2.44M in total compensation at Labcorp Holdings, including $1.20M salary and $1.24M bonus. Most recently acquired 11,124 shares in May 2024. Currently holds stock worth $94.12M. Has donated $58.93M in stock to charitable causes. Led Labcorp Holdings as CEO for 12 years.
Compensation History
Annual executive compensation data for David P. King, including salary, bonuses, and stock awards.
Year
2019
Total Compensation
$2.44M
Salary
$1.20M
Bonus
$1.24M
Other
$0.00
Salary
$1.20MBoard Justification
The compensation philosophy emphasizes performance-based compensation to align executive pay with company performance and shareholder returns.
Bonus
$1.24MBoard Justification
Mr. King received a MIB payout at 103 percent of target for the 2019 fiscal year, reflecting his full 2019 MIB Plan opportunity.
Other Compensation
$0.00Board Justification
No additional compensation details provided for 2019.
Restricted Stock
Board Justification
No specific vested stock information provided for 2019.
Performance Metrics
The performance metrics for 2019 included consolidated revenues and consolidated adjusted operating income.
David P. King
Ex-CEO of Labcorp Holdings
Sector of Economy
Healthcare
Born
July 30, 2024 - 1 years ago
CEO of Labcorp Holdings for
12 years 9 months (Jan 2007 - Oct 2019)
Previous Experience
Unknown
Holdings
Track David P. King's stock holdings and portfolio value over time.
Total Stock Sold
$158.74M
$158.73M
1,469,062.284 LH shares
$2.20K
30 CAH shares
What if they kept their stock?
If David P. King didn't sell their stock, today they would have:
Extra LH1,469,062.284 shares worth $379.59M and CAH30 shares worth $5.96K.
This is 139.14% and $220.86M more than what they got when they sold the stock.
Charitable Transactions
228,072.996 shares
LH
Recent Charitable Transactions
2,084 shares
LH
Aug 13, 2018
Charity
57,413 shares
LH
Dec 31, 2017
Charity
1,650 shares
LH
Aug 2, 2017
Charity
31,601 shares
LH
Nov 14, 2016
Charity
57,884 shares
LH
Dec 31, 2012
Charity
43,758 shares
LH
Jul 2, 2012
Charity
Insider Trading
David P. King's recent stock transactions, purchases, and sales filed with the SEC.
11,124 shares
PRVA
May 22, 2024
Received
7,758 shares
PRVA
Jul 1, 2023
Received
7,425 shares
PRVA
May 27, 2022
Received
7,609 shares
PRVA
Apr 28, 2021
Received
$5.00M
LH at $160.00/share
May 5, 2020
Sale
54,995 shares
LH
Mar 30, 2020
Received
$4.99M
LH at $165.23/share
Oct 28, 2019
Sale
92,417 shares
LH
Apr 1, 2019
Received
2,084 shares
LH
Aug 13, 2018
Charity
$8.78M
LH at $175.70/share
May 23, 2018
Sale
Rivals
Compare David P. King with competitor CEOs and industry peers.
Brian S. Tyler
CEO of McKesson
2023 Compensation
Stock
$53.90M
Salary
$1.49M
Bonus
$0.00
Other
$864.73K
Total Holdings
$230.10K
August J. Troendle
Founder and CEO of Medpace Holdings, Inc.
2023 Compensation
Stock
$0.00
Salary
$825.00K
Bonus
$814.42K
Other
$17.33K
Total Holdings
$513.58M
James E. Davis
CEO of Quest Diagnostics
2023 Compensation
Stock
$0.00
Salary
$1.18M
Bonus
$1.36M
Other
$346.71K
Total Holdings
$31.88M
Eric M. Green
CEO of West Pharmaceutical Services
2023 Compensation
Stock
$0.00
Salary
$1.14M
Bonus
$1.67M
Other
$92.48K
Total Holdings
$159.06M
Stanley M. Bergman
CEO of Henry Schein
2023 Compensation
Stock
$0.00
Salary
$1.63M
Bonus
$643.65K
Other
$341.74K
Total Holdings
$49.43M